All In MedTech

Device Trial Radar · NCT03903471

22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA

Comparion of 22G-ProCore and 22G-Standard Needle in Diagnosis of Lymphadenopathy Via EBUS-TBNA: A Prospective, Single-center, Randomized Controlled Clinical Trial

Last checked: Nov 20, 2026Latest source record: Sep 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

600

Planned (sponsor's estimate)

Start

Oct 8, 2022

Primary completion

Oct 8, 2023

Study completion Oct 8, 2023

Sponsor

Lead sponsor
Jiayuan SunAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 4, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study is to compare the performance of 22G-ProCore and 22G-Standard needle in diagnosis of mediastinal and hilar lymphadenopathy via EBUS-TBNA with the purpose to explore the optimal technique for obtaining diagnostic material.

Conditions

  • Lymph Node Disease

Interventions

  • 22G-ProCore Endobronchial Ultrasound NeedleDevice

    EchoTip Procore® Endobronchial HD Ultrasound Biopsy Needle, COOK

  • 22G-Standard Endobronchial Ultrasound NeedleDevice

    EchoTip® Ultra Endobronchial High Definition Ultrasound Needle, COOK

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diagnostic yield of 22G-ProCore needleTime frame: up to 6 months
  2. Diagnostic yield of 22G-Standard needleTime frame: up to 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Chest Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.